600165.SH
Ningxia Zhongke Biotechnology Co., Ltd.
SSE · Basic Materials · Steel · CN
CNY 2.81
+1.08%Year over year
Reported trailing growth
- Revenue
- +21.6%
- EBITDA
- —
- EBIT
- +81.0%
- EPS
- +73.5%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -9.7%
- EBITDA
- +104.2%
- EBIT
- +80.3%
- Net income
- +83.2%
- EPS
- +92.9%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026